Хитозан и перспективы его использовавния

 

32. Koping-Hoggard M., Varum K.M., Issa M., et al. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther. 2004; v. 11: 19: 1441—1452.

 

33. Tang C., Inman M.D., van Rooijen N., et al. Th type 1 stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J. Immunol. 2001; v. 166: 1471—1481.

 

34. Kumar M., Kong X., Behera A.K., et al. Chitosan IFN-γ-pDNA nanoparticles (CIN) therapy for allergic asthma. Genet.Vaccines Therapy. 2003; 1 (1): 3.

 

35. Filipovic-Grcic J., Skalko-Basnet N., Jalsenjak I. Mucoadhesive chitosan-coated liposomes: characteristics and stability. J. Microencapsul. 2001; v. 18: 3-12.

 

36. Chen J., Yang W.L., Li G., et al. Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. World J. Gastroenterol. 2004; v. 10:1: 112-116.

 

37. von Boehmer H. Oral tolerance: is it all retinoic acid? J. Exp. Med. 2007; v. 204: 1737—1739.

 

38. Li F., Wang L., Jin X.M., et al. The immunologic effect of TGF-beta 1 chitosan nanoparticle plasmids on ovalbumin-induced allergic BALB/c mice.Immunobiol. 2009; v. 214: 2: 87-99.

 

39. Moffart M.F., Cookson W.O.C. Gene therapy for peanut allergy. Nat. Med. 1999; v. 5: 4: 380-381.

 

40. Roy K., Mao H.Q., Huang S.K., Leong K.W. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 1999; v. 5: 4: 387-391.

 

41. Chew J.L., Wolfowicz C.B., Mao H.Q., et al. Chitosan nanoparticles DNA encoding house dust mite allergen, Der p 1 oral vaccination in mice. Vaccine.2003; v. 21: 2720—2729.

 

42. Hershberg R.M., Mayer L.F. Antigen processing and presentation by intestinal epithelial cells — polarity and complexity.Immunol.Today. 2000; v. 21: 1: 123-128.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Оглавление

1. Ведение…………………………………………………………………………………1

1.2. Исторические  сведения создания и применения  хитозана………………………2

1.3. Химическое  строение и свойства хитина  и хитозана…………………………….4

2. Биоактивные  производные хитозана………………………………………………..7

3. Применение  хитозана………………………………………………………………..10

4. Применение  хитозана в качестве матрицы  для транспорта и синтеза лекарственных веществ……………………………………………………………………………..13

Выводы………………………………………………………………………………….21

Заключение……………………………………………………………………………..22

Список использованной литературы…………………………………………………23